- Board of Directors
- Senior Management
AHMED ADEL BADRELDIN
(Chairman of the Board)
Mr. Badreldin is a private equity fund manager. In 2014 he backed the CHC management team through a number of acquisitions to create Cleopatra Hospital Group. Prior to CHC, Mr Badreldin was also non-executive director of Integrated Diagnostics Holdings, the largest Egyptian diagnostics business, which he helped create in 2012 through the merger of AlBorg and AlMokhtabar. Mr. Badreldin possesses over 15 years’ experience in financial services and holds an MBA from the Cranfield School of Management and a BSc in Mechanical Engineering from the American University in Cairo.
DR. AHMED EZZELDIN MAHMOUD ABDELAAL
(Chief Executive Officer)
Dr. Ahmed Ezzeldin Mahmoud Abdelaal joined the Group in June 2015 after previously working at Johnson & Johnson as a director overseeing government affairs and policy for MENA and Pakistan. He had earlier served as managing director responsible for the medical sector at the same company, covering Egypt and Libya. There, he played a role in the development of healthcare systems in Egypt and the Middle East through the creation of four centres of excellence that together trained more than 1,500 healthcare professionals annually from 2006 through 2012. Prior to that, Dr. Ezzeldin worked at GlaxoSmithKline, where he led the Middle East region integration plan as part of the merger of SmithKline & Beecham and Glaxo Wellcome, as well as having roles in resource planning and segmentation projects. He had earlier spent 18 years with pharmaceutical company Merck Sharp & Dohme. Dr. Ezzeldin is past co-chairman of the Healthcare and Pharmaceutical Committee of the American Chamber of Commerce in Egypt and was a member of the Egyptian Ministry of Health’s Supreme Committee for Registration of Medical and Diagnostics Devices. He holds a Bachelor Degree in Pharmaceutical Science from Cairo University.
DR. MOHAMED AWAD TAG EL DIN
(Independent Non-Executive Director)
Dr. Awad Tag El Din was the Egyptian Minister of Health from March 2002 to December 2005. Prior to that, he was the president and vice president of Ain Shams University for one and four years, respectively He holds a Bachelor Degree in medicine, two diplomas in internal medicine and pulmonology diseases and a PhD from Ain Shams University. He is also a professor and consultant of pulmonology.
NABIL WALID KAMHAWI
(Independent Non-Executive Director)
Mr. Kamhawi has over 40 years of consulting, audit and advisory experience in Europe and the Middle East in a wide range of industries. He was the managing partner of Ernst & Young in Egypt following its integration with Arthur Andersen, of which he was the managing partner. Mr. Kamhawi holds a Bachelor Degree in commerce (accounting) from Ain Shams University and is a member of the Institute of Chartered Accountants in England and Wales.
OMAR ATEF KINAWY
(Independent Non-Executive Director)
Mr. Kinawy joined the Group in 2015. Prior to that, he was the former deputy head of the Egyptian General Intelligence and graduated from the Egyptian Military College in 1968.
OMAR EZZ AL ARAB
Mr. Ezz Al Arab is a member of Abraaj Group’s MENA investment team and is involved in all aspects of the investment process including deal origination, execution and portfolio management. Mr. Ezz Al Arab has over 10 years of private equity and investment banking experience in Europe and the Middle East in sectors such as oil and gas, healthcare, education and fast-moving consumer goods. Prior to joining Abraaj in 2009, Mr. Ezz Al Arab worked at JP Morgan in London as part of the Mergers & Acquisitions team in the Natural Resources Group where he advised on more than USD 15 billion worth of transactions. Mr. Ezz Al Arab holds a Bachelor of Arts degree in Law and Business from the University of Warwick, UK.
SAMIA EL BAROUDY
Mrs. Samia El Baroudy brings global experience in the private equity sector through being a member of an investment team that oversees investments in a variety of sectors in Egypt including the healthcare sector. She has held direct responsibility for the different portfolio companies including Integrated Diagnostics Holdings, OMS, ECCO and North Africa Hospital Holdings Group (NAHHG). Currently, Mrs. Samia is part of a team that is responsible for setting up the largest hospital platform in North Africa. Prior to joining the private equity sector, she was a consultant at Booz & Co. She holds a master’s degree in Management Science & Engineering and a bachelor’s degree in Economics, both from Stanford University.
(Independent Non-Executive Director)
Mr. Tarek Kabil is the former Minister of Trade and Industry for Egypt from 2015-2018. He brings over 40 years of global professional experience in a variety of sectors including Government, Private Equity, and FMCGs across US, Asia, Middle East, and Africa. He has led several international organisations including serving as President and CEO of PepsiCo Middle East and Africa. Currently, Mr. Tarek Kabil serves as the CEO and Chairman of Business Solutions Consulting Group, as well as a board member and advisor in different sectors such as FMCG, Banking, and Education.
Dr. Manal Hussein Abdel Razek
(Independent Non-Executive Director)
Dr. Manal Hussein Abdel Razek joined CHG’s Board of Directors in April 2020. Dr. Abdel Razek is also the Executive Chairwoman of New City Housing & Development, formerly Orascom Housing Communities a position she has held since June 2018. Dr. Abdel Razek also has a 23-year-long experience in the public sector having served in the Egyptian government as Deputy Minister of Foreign Trade and Deputy Minister of Finance for nine years, and as a member of the Shura Consultative Council appointed by the President for seven years. Dr. Abdel Razek obtained her Bachelor of Science with Honours in Mass Communication in 1986 from Cairo University. She subsequently obtained her Master of Arts in Public Administration from the American University in Cairo in 2000. In June 2001, she earned the Frank G. Wisner Award in recognition of her outstanding master’s thesis. She then obtained her Ph.D. dissertation in Public Administration with highest honours from the Faculty of Economics and Political Science, Cairo University in 2008.
(Independent Non-Executive Director)
Mohamed Roushdy joined CHG’s Board of Directors in April 2020. Mr. Roushdy is currently also the President of Amoun Group Middle East and brings over 39 years of experience in the Pharmaceutical sector, having held the positions of Chairman and CEO of Amoun Pharmaceuticals Egypt from December 2012 until December 2017. Prior to joining Amoun, he was CEO of Pfizer Middle East, a position which saw him oversee operations across 14 countries. Mr. Roushdy holds a Master’s Degree in Pharmacology and a Bachelor Degree in Business Administration.
Dr. Sherif El Kholy
(Independent Non-Executive Director)
Dr. Sherif El Kholy join CHG’s Board of Directors in April 2020. Dr. El Kholy is currently a Partner at Actis, and since joining the company in 2004 has played various deal leadership, execution, investment management and exit roles across North Africa in Edita Food Industries, Emerging Markets Knowledge Holdings, El-Rashidi El-Mizan, Mo'men Group, Orascom Telecom Algeria, as well as leading Lekela Power's push into Egypt. Dr. El Kholy holds a Ph.D. in Economics and an Master’s of Science in Finance and Economic Development both from the University of London.
DR. AHMED EZZ EL-DIN
Group Chief Executive Officer
Dr. Ahmed Ezz El-Din brings over 37 years of healthcare experience to the group and a deep insight into healthcare businesses in Egypt. Prior to assuming his role as the Group’s CEO, Dr. Ezz El-Din was the Director of Government Affairs & Policy – Middle East, North Africa & Pakistan at Johnson & Johnson Medical, where he also held the position of Managing Director for Egypt & Libya. Prior to that, Dr. Ezz El-Din also held key positions at GSK, including Sales & Commercial Director at GSK Egypt and Sudan Country Manager. He holds over 18 years of global experience with MSD under his belt. Dr. Ezz El-Din has a Bachelor Degree in Pharmaceutical Science from Cairo University.
DR. MOHARRAM EL-BADAWY
Group Chief Operating Officer
Prior to joining the Group in June 2016, Dr. El-Badawy was the Professor of Radio Diagnosis at the National Cancer Institute for over 30 years before heading the department for nine years. His previous roles also include board member of Radio Diagnosis Department in Daghastani Hospital Jeddah, K.S.A for six years, Referee for the Egyptian Journal of the National Cancer Institute, and Referee for the Journal of Egyptian Society.
Ahmed Gamal Eldin
Group Chief Financial Officer
Mr. Ahmed Gamal Eldin is the Group’s Chief Financial Officer, a position he took on in 2019. Mr. Gamal Eldin brings over 26 years of varied experience in financial management, corporate strategy, and investment banking. He started his career as an External Auditor at KPMG before moving to the corporate finance arm where he provided financial advisory services including business valuation, M&A, fund raising, and corporate restructuring to a large number of corporates engaged in various sectors. Mr. Gamal Eldin has also led the Control and Reporting Function at Cadbury and PepsiCo. During his time there, he led the functional transformation towards building world-class finance and control processes. He also has pharmaceutical industry exposure having worked as MENA Finance and Strategy Director at Lundbeck. Mr. Gamal Eldin also led the finance function as the CFO of Egypt Foods Group where he led business transformation initiatives and strategic change management plans across the Group. Mr. Gamal Eldin holds a Master of Business Administration from the American University in Cairo and he is Certified Management Accountant ‘CMA’ from the American Institute of Management Accountants. He is also a keynote speaker in various financial and strategic management forums.
Chief Human Resources Officer
Ms. Marwa El-Abassiry joined the Group in February 2015. Previously, she was the Human Resources Business Partner and Head of HR at Electrolux Egypt. Ms. El-Abassiry holds a Bachelor of Arts from the Al-Alsun Faculty at Ain Shams University, a Senior Professional Human Resources (SPHR) Certificate, a Business Coaching Certificate from Life Coaching Egypt and a Business Administration Diploma from the American University in Cairo.
DR. MOHAMED IBRAHIM
Chairman of the Medical Council
Dr. Mohamed Ibrahim is the Chairman of the Group’s Medical Council, a role he took on in 2019. Dr. Ibrahim joined Cleopatra Hospital in 2001 as Medical Director and later assumed his role as Managing Director of the Group’s flagship hospital in 2006. With over 36 years of medical experience, Dr. Ibrahim began his career as a physician at the Military Hospital and was Commander of the Navy Hospital in the United Arab Emirates. He holds a Master’s Degree in Hospital Management from the American University in Cairo.
DR. HANI VICTOR
Cleopatra and Queens Hospitals Managing Director
Dr. Hani Victor is the Managing Director at Cleopatra Hospital and Queens Hospital. Dr. Victor joined the Group in 2018 and assumed the role of NBH’s Managing Director. He brings over 19 years of experience having previously held the position of Chairman of the medical council in El Katib Hospital. He is an international course director and educator in all the European Resuscitation Council courses (ERC) and a member of the Course Management Committee (CMC). He is also Vice President of the Egyptian Resuscitation Council (EgRC) and one of the founders and the Secretary General of the Egyptian Trauma Society (EgTS).
DR. NANIS ADEL
Cairo Specialized Hospital Managing Director
Dr. Nanis has over 24 years of experience in the healthcare industry having held several key positions across an array of medical establishments including Director of Emergency Hospital at Ain Shams University Hospital, Advisor to the Minister of Health and Population for Hospital Affairs, and Chairman of the Scientific Council for Health Facilities Fellowship. In 2004, Dr. Nanis was awarded a PhD in Internal Medicine from Ain Shams University.
DR. HAMADA ABD EL HAMEED
Nile Badrawi Hospital Managing Director
Dr. Hamada Abd El Hameed is the Managing Director at Nile Badrawi Hospital, a position he took on in 2019. Dr. Hamada joined the group in August 2017 assuming the role of Al Shorouk Hospital Managing Director. Prior to joining the Group, Dr. Hamada was the Regional Operations Manager at Andalusia Group (Cairo - Alexandria) and also served as Managing Director of Andalusia Hospital in Maadi from 2010 to 2016. Dr. Hamada holds a Master’s Degree in General Surgery and an Egyptian Fellowship in Surgery, a Master’s Degree in Business Administration, as well as several Diplomas including Quality Management from the American University in Cairo and a Diploma in Hospital Administration.
Dr. Sameh Wasfy
Al Shorouk Hospital Managing Director
Dr. Sameh Wasfy is the Managing Director at El Shorouk Hospital, a position he took on in 2020. Prior to joining the Group, Dr Sameh worked as a General Manager at Italian Hospital for five years. Prior to his time with Italian Hospital, Dr. Sameh held various positions including Managing Director at the Catheter Center in Hayat Hospital, Hospital General Manager at Borg-Mina Hospital, and Head of Imaging Department at the National Institute of Diabetes and Endocrinology. Dr. Sameh holds a Bachelor Degree in Medicine and Surgery from Cairo University.
Dr. Saad Adel
El Katib Hospital and Bedaya Managing Director
Dr. Saad Adel is the Managing Director at El Katib Hospital and Bedaya, positions he took on in 2019 and 2020, respectively. Prior to joining the group, Dr. Saad worked at Al Andalusia Group for five years holding the roles of Operation Director, Hospital Director, and finally Regional Operations Director. Prior to his time with Al Andalusia Group, Dr. Saad also worked as Medical Director at Abdulatif Jameel Hospital in Jeddah for two years, as a Lecturer at the International Academy for Health Science, and as Assistant Manager at Al Safaa Medical Center. Dr. Saad holds a Bachelor Degree in Medicine from Ain Shams University.
Dr. Waleed Anwar
Queens Hospital Managing Director
Dr. Waleed Anwar is the Managing Director at Queens Hospital, a position he took on following the acquisition of the hospital by CHG in 2019. Prior to joining the group, Dr. Waleed was Assistant Professor of Nephrology and a Consultant at Ain Shams University Faculty of Internal Medicine and Hospitals. Dr. Waleed has over 15 years of experience in the field of Nephrology with his previous experience including Head of Nephrology Department of Hemodialysis Unit at Palestine Hospital as well as Head of the Nephrology Department and Hemodialysis Unit at Golf International Hospital. Dr. Waleed holds a Bachelor Degree in Medicine from Ain Shams University and a Master’s Degree in Internal Medicine from the same university.
DR. MARWA AL RUBY
Group OPD Director
Dr. Marwa Al Ruby is currently the Director of Polyclinics at CHG, a position she took on in 2019. Dr. Marwa joined Cleopatra Hospital in March 2017 as Outpatient Department Manager and later assumed her role as OPD Director of the Group in July 2018. Prior to joining the group, Dr. Marwa held several positions including Medical Auditor, Project Manager, and OPD Manager in Andalusia Group for Medical Services.
DR. KAREEM AWAD ALI
Director of Pharmaceutical Services
Dr. Kareem Awad Ali is currently the Director of Pharmaceutical Services. Dr. Kareem holds 12 years of experience in pharmacy management. Prior to joining CHG, Dr. Kareem was part of As-salaam international Hospital until 2014, and was Andalusia Pharmacy Manager until 2016. Dr. Kareem has been CHG’s Group supply chain manger for 4 years, and currently serves as the Director of Pharmaceutical service & Managing Director of CHG Pharma. He assumed both these roles in 2020, and is currently managing 12 Pharmacies across CHG. Dr. Kareem graduated from faculty of pharmacy Cairo university 2009. He also holds a Clinical Pharmacy Diploma from Ain Shams University, as well as a Master of Business Administration MBA with a specialization in Project management. Furthermore, Dr. Kareem holds a Professional Supply Chain Diploma from the AUC.
Supply Chain Associate Director
Ms. Eman Fouda joined the Group in December 2015 as Group Supply Chain Manager, and brings over 20 years of professional experience in the healthcare industry in Egypt. Prior to assuming her current role as the Group’s Supply Chain Associate Director, Ms. Fouda was the Regional Supply Chain Manager Egypt & Middle East at Johnson & Johnson Medical, where she also held the position of Regional Commercial Manager for Egypt & Libya at Johnson & Johnson Medical. During her career at Johnson & Johnson Medical, she played a key role in the development of Supply Chain department in Egypt and the Middle East through executing and implementing strategies to establish the Supply Chain function in Egypt and Middle East. Ms. Fouda has a B.Sc. of Commerce from Ain Shams University, and obtained her MBA in Globalization from Maastricht Business School in Holland.
Chief Information Technology Officer
Mr. Amr El-Ashkar joined the Group in November 2015. Previously, he was Chief Information Officer at Integrated Diagnostics Holdings and worked at OMS, United Nations and ITWorx. He holds a Bachelor Degree in Computer Science from Ain Shams University, a Master of Science in Computer Science from the University of Louisville and a Doctorate in Business Administration from Maastricht Business School, Holland.
DR. KHALED EL MOUNIRY
Chief Revenue Officer
Dr. Khaled joined the Group in 2020 as the Chief Revenue Officer. Amongst his main responsibilities is driving growth in the Group’s digitalization drive. Prior to joining CHG, Dr. Khaled was Vezeta’s Managing Director. Dr. Khaled offers great value as he previously also held prominent positions such as AstraZeneca’s country president for Egypt & North Africa. He holds an MBA from Leicester University in the UK.
DR. NAGWA EL HOSSEINY
Group Quality Director
Dr. Nagwa El Hosseiny is a Professor of Internal Medicine at Cairo University. She joined the Group in November 2016 to head the Quality Control Department. She was previously Quality Consultant and Head of the Egyptian Executive Committee of Accreditation at the Ministry of Health and Population. Dr. El Hosseiny also held positions in the private healthcare sector, including Quality Manager at Dar Al Fouad Hospital and Senior Consultant & Technical Director at Logistics Company for Consultation where she led, guided and prepared quality control teams for JCI accreditation. Dr. El Hosseiny is also a member of the Scientific Board of Arab Healthcare and Accreditation and a member of the JCI’s Middle East Advisory Board.
Corporate Strategy & Investor Relations Director
Mr. Hassan Fikry joined the Group in 2015 as Business Analysis Manager. Mr. Fikry then went on to manage the Corporate Strategy & Development team before taking on his current position as Corporate Strategy & Investor Relations Director. Mr. Fikry brings valuable business development experience to the Group, having previously been the Co-Founder & Executive Director of El-Seha Laboratories, the Executive Director of the Ahmed H.Fikry Medical Centre, and Coordinator, Strategic Planner at Orascom Telecom Holding. He holds a Bachelor of Commerce & Economics from the John Molson School of Business at Concordia University and completed a Mini MBA in Telecoms.
Soliman El Aasser
Mr. Soliman Al Aasser joined the Group in 2019 as Transformation Director. Prior to assuming his role at CHG, Mr. Soliman was an Associate in the Investment team of a leading private equity firm responsible for executing and implementing strategies to increase the value integration of the firm’s healthcare platform. Prior to this Mr. Soliman held the role of Co-founder & Managing Director of both El Sastre shirt brands and Mediterranean Golf Tour. Mr. Soliman holds a Bachelor Degree in Economics from the University of Cairo and is a Certified Chartered Financial Analyst having passed all three exams.
Group Commercial Director
Mr. Salah is the Group’s Contracting and Sales Director, and brings over 16 years of industry experience to the Group. He previously held roles at the National Bank of Egypt Insurance Company, Al-Salaam Hospital, Nova Pharmaceutical Company as well as Nagor and Striker. Mr. Salah holds a BSc from Cairo University and an MBA with a marketing focus from the Arab Academy for Science, Technology, and Maritime.
Group Marketing Director
Mr. Ramez Adib joined the Group in April 2019 as Marketing Director. He brings 19 years of experience ranging from market research, to brand and portfolio building, and management within multinational companies. Prior to joining CHG, Mr. Ramez held the Marketing Director position in Proper Move. He holds a Bachelor of Arts in Journalism and Mass Communication from the American University in Cairo.
NADER RAFAEL KAMEL
General Legal Counsel
Mr. Nader joined the Group in December 2020 as the Group General Legal Counsel backed by 30 years of experience across several industries with expertise in corporate affairs, legislation, and governance. His work history includes high profile institutions such as Baker & McKenzie International Law Firm, British American Tobacco, Orange, Al Ahram Beverage Company – Heineken International, and Hyde Park Development. Mr. Nader is responsible for the Group’s legal compliance and providing legal counsel to the management. Mr. Nader has a bachelor degree in law from Cairo University, member of the International Bar Association (IBA), UK, enrolled in the Egyptian Bar of Association before supreme courts, enrolled as an International Arbitrator before the Arab Authority for Arbitration & Law.
ENG. AMR SHERIF
Group Projects & Engineering Director
Eng. Amr Sherif joined the Group in 2017 as Projects and Engineering Director responsible for overseeing the Group’s projects and expansion plans. He previously served as Projects Director at Dar Al Fouad Hospital during which he was responsible for overseeing the new Dar Al Fouad Hospital project in the Cairo district of Nasr City. Eng. Sherif also holds years of experience as Project Manager for major engineering projects during his time at the French Arab Engineering Consulting Company. Eng. Sherif holds a Bachelor of Architecture from Ain Shams University and is an architecture consultant at the Engineers Syndicate.
Internal Audit Associate Director
Ms. Ola Ahmed joined the Group in January 2017 as Internal Audit Manager with over 14 years of experience in establishing an Internal Audit Function. Her expertise covers internal control and corporate governance review, risk assessment and risk-based auditing. She previously held positions at a number of reputable organisations, including Ernst & Young, PricewaterhouseCoopers, Orascom for Construction Industries, Magrabi, General Motors and Al Sharkeya for Sugar Industries. The Internal Audit Department reports administratively to the Group’s CEO and functionally to the Board’s Audit Committee.